Literature DB >> 20889891

Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia.

Rodney James1, Joel Barratt, Deborah Marriott, John Harkness, Damien Stark.   

Abstract

A retrospective analysis was undertaken to determine the seroprevalence of Entamoeba histolytica infection in Sydney, Australia. Using an enzyme-linked immunosorbent assay, 429 high risk human immunodeficiency virus (HIV)-infected men who have sex with men (MSM), 446 low risk HIV-uninfected MSM, and 456 HIV-uninfected controls were assessed. Seroprevalence rates were 5.13% for the high risk HIV-infected MSM group, 0.22% for the low risk HIV-uninfected MSM group, and 0.44% for the control group. We found that high risk HIV-infected MSM have a significantly greater seroprevalence of E. histolytica with a relative risk of 22.87, when compared with low risk HIV-uninfected MSM and 11.69 when compared with controls. These findings show that in Sydney, sexually active HIV-infected MSM are at greater risk of developing amoebic disease caused by E. histolytica than HIV-uninfected MSM and the general population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889891      PMCID: PMC2946768          DOI: 10.4269/ajtmh.2010.10-0231

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

Review 1.  Amebiasis.

Authors:  Rashidul Haque; Christopher D Huston; Molly Hughes; Eric Houpt; William A Petri
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

2.  Endemic invasive amoebiasis in northern Australia.

Authors:  James S McCarthy; David Peacock; Kevin P Trown; Patrick Bade; William A Petri; Bart J Currie
Journal:  Med J Aust       Date:  2002-11-18       Impact factor: 7.738

Review 3.  Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.

Authors:  J A Walsh
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

4.  Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests.

Authors:  R Haque; N U Mollah; I K Ali; K Alam; A Eubanks; D Lyerly; W A Petri
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 5.  Amoebiasis.

Authors:  Samuel L Stanley
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

6.  Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan.

Authors:  K Ohnishi; Y Kato; A Imamura; M Fukayama; T Tsunoda; Y Sakaue; M Sakamoto; H Sagara
Journal:  Epidemiol Infect       Date:  2004-01       Impact factor: 2.451

Review 7.  Entamoeba histolytica: an update.

Authors:  William Stauffer; Jonathan I Ravdin
Journal:  Curr Opin Infect Dis       Date:  2003-10       Impact factor: 4.915

8.  Seroprevalence of Entamoeba histolytica infection in female outpatients at a sexually transmitted disease sentinel clinic in Tokyo, Japan.

Authors:  Jun Suzuki; Seiki Kobayashi; Ise Iku; Rie Murata; Yoshitoki Yanagawa; Tsutomu Takeuchi
Journal:  Jpn J Infect Dis       Date:  2008-05       Impact factor: 1.362

Review 9.  Amebiasis: introduction, current status, and research questions.

Authors:  R L Guerrant
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

10.  Invasive amebiasis in men who have sex with men, Australia.

Authors:  Damien Stark; Sebastian J van Hal; Gail Matthews; John Harkness; Deborah Marriott
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more
  15 in total

Review 1.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Epidemiology of Domestically Acquired Amebiasis in Japan, 2000-2013.

Authors:  Masahiro Ishikane; Yuzo Arima; Atsuhiro Kanayama; Takuri Takahashi; Takuya Yamagishi; Yuichiro Yahata; Tamano Matsui; Tomimasa Sunagawa; Tomoyoshi Nozaki; Kazunori Oishi
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

3.  Amebiasis deaths in the United States.

Authors:  Chien-Ching Hung; Sui-Yuan Chang; Dar-Der Ji
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

4.  Antiamoebic drugs for treating amoebic colitis.

Authors:  Maria Liza M Gonzales; Leonila F Dans; Juliet Sio-Aguilar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-09

5.  Prevalent and incident HIV diagnoses among Entamoeba histolytica-infected adult males: a changing epidemiology associated with sexual transmission--Taiwan, 2006-2013.

Authors:  Yi-Chun Lo; Dar-Der Ji; Chien-Ching Hung
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

6.  Underestimated Amoebic Appendicitis among HIV-1-Infected Individuals in Japan.

Authors:  Taiichiro Kobayashi; Koji Watanabe; Hideaki Yano; Yukinori Murata; Toru Igari; Kumiko Nakada-Tsukui; Kenji Yagita; Tomoyoshi Nozaki; Mitsuo Kaku; Kunihisa Tsukada; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

7.  Outbreak of intestinal amoebiasis among men who have sex with men, Barcelona (Spain), October 2016 and January 2017.

Authors:  Laura Escolà-Vergé; Maider Arando; Martí Vall; Roger Rovira; Mateu Espasa; Elena Sulleiro; Pere Armengol; Francesc Zarzuela; María-Jesús Barberá
Journal:  Euro Surveill       Date:  2017-07-27

8.  Seroprevalence of Entamoeba histolytica infection among Chinese men who have sex with men.

Authors:  Feng Zhou; Mufei Li; Xiangwei Li; Yu Yang; Cong Gao; Qi Jin; Lei Gao
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

Review 9.  Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control.

Authors:  Kevin Kline; James S McCarthy; Mark Pearson; Alex Loukas; Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31

10.  Increases in Entamoeba histolytica Antibody-Positive Rates in Human Immunodeficiency Virus-Infected and Noninfected Patients in Japan: A 10-Year Hospital-Based Study of 3,514 Patients.

Authors:  Yasuaki Yanagawa; Naoyoshi Nagata; Koji Watanabe; Kunihisa Tsukada; Katsuji Teruya; Yoshimi Kikuchi; Hiroyuki Gatanaga; Junichi Akiyama; Naomi Uemura; Shinichi Oka
Journal:  Am J Trop Med Hyg       Date:  2016-06-13       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.